J. Bower, D. Maraganore, S. Mcdonnell, and W. Rocca, Influence of strict, intermediate, and broad diagnostic criteria on the age- and sex-specific incidence of Parkinson's disease, Movement Disorders, vol.47, issue.5, pp.819-825, 2000.
DOI : 10.1002/1531-8257(200009)15:5<819::AID-MDS1009>3.0.CO;2-P

S. Parashos, D. Maraganore, O. Brien, P. Rocca, and W. , Medical Services Utilization and Prognosis in Parkinson Disease: A Population-Based Study, Mayo Clinic Proceedings, vol.77, issue.9, pp.918-925, 2002.
DOI : 10.1016/S0025-6196(11)62259-3

A. Elbaz, J. Bower, and B. Peterson, Survival Study of Parkinson Disease in Olmsted County, Minnesota, Archives of Neurology, vol.60, issue.1, pp.91-96, 2003.
DOI : 10.1001/archneur.60.1.91

W. Rocca, S. Mcdonnell, and K. Strain, Familial aggregation of Parkinson's disease: The Mayo Clinic family study, Annals of Neurology, vol.13, issue.4, pp.495-502, 2004.
DOI : 10.1002/ana.20228

S. Mcdonnell, D. Schaid, and A. Elbaz, Complex segregation analysis of Parkinson's disease: The Mayo Clinic Family Study, Annals of Neurology, vol.32, issue.5, pp.788-795, 2006.
DOI : 10.1002/ana.20844

M. Polymeropoulos, C. Lavedan, and E. Leroy, Mutation in the -Synuclein Gene Identified in Families with Parkinson's Disease, Science, vol.276, issue.5321, pp.2045-2047, 1997.
DOI : 10.1126/science.276.5321.2045

R. Kruger, W. Kuhn, and T. Muller, AlaSOPro mutation in the gene encoding ??-synuclein in Parkinson's disease, Nature Genetics, vol.277, issue.2, pp.106-108, 1998.
DOI : 10.1126/science.277.5324.387

J. Zarranz, J. Alegre, and J. Gomez-estaban, The new mutation, E46K, of ??-synuclein causes parkinson and Lewy body dementia, Annals of Neurology, vol.62, issue.suppl 1, pp.164-173, 2004.
DOI : 10.1002/ana.10795

A. Singleton, M. Farrer, and J. Johnson, ??-Synuclein Locus Triplication Causes Parkinson's Disease, Science, vol.302, issue.5646, p.841, 2003.
DOI : 10.1126/science.1090278

M. Farrer, J. Kachergus, and L. Forno, Comparison of kindreds with parkinsonism and ?-synuclein genomic multiplications, Annals of Neurology, vol.13, issue.2, pp.174-179, 2004.
DOI : 10.1002/ana.10846

M. Chartier-harlin, J. Kachergus, and C. Roumier, ??-synuclein locus duplication as a cause of familial Parkinson's disease, The Lancet, vol.364, issue.9440, pp.1167-1169, 2004.
DOI : 10.1016/S0140-6736(04)17103-1

P. Ibanez, A. Bonnet, and B. Debarges, Causal relation between ??-synuclein locus duplication as a cause of familial Parkinson's disease, The Lancet, vol.364, issue.9440, pp.1169-1171, 2004.
DOI : 10.1016/S0140-6736(04)17104-3

K. Nishioka, S. Hayashi, and M. Farrer, Clinical heterogeneity of ??-synuclein gene duplication in Parkinson's disease, Annals of Neurology, vol.56, issue.2, pp.298-309, 2006.
DOI : 10.1002/ana.20753

M. Spillantini, M. Schmidt, V. Lee, J. Trojanowski, R. Jakes et al., -Synuclein in Lewy bodies Increased susceptibility to sporadic Parkinson's disease by a certain combined -synuclein/ apolipoprotein E genotypeSynuclein gene haplotypes are associated with Parkinson's diseaseSynuclein promoter confers susceptibility to Parkinson's disease al. Human and mouse -synuclein genes: comparative genomic sequence analysis and identification of a novel gene regulatory element, Nature. Ann Neurol. Hum Mol Genet. Ann Neurol. Genome Res, vol.38845105611, issue.18, pp.839-840611, 1997.
URL : https://hal.archives-ouvertes.fr/in2p3-00003711

O. Chiba-falek, R. Nussbaum, O. Chiba-falek, J. Touchman, and R. Nussbaum, Effect of allelic variation at the NACP-Rep1 repeat upstream of the -synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system Functional analysis of intra-allelic variation at NACP- Rep1 in the -synuclein gene, Lindquist S. Yeast cells provide insight into alpha-synuclein biology and pathobiology, pp.3101-3109, 2001.

E. Tan, T. Matsuura, S. Nagamitsu, M. Khajavi, J. Jankovic et al., Polymorphism of NACP-Rep1 in Parkinson's disease: An etiologic link with essential tremor?, Neurology, vol.54, issue.5, pp.1195-1198, 2000.
DOI : 10.1212/WNL.54.5.1195

E. Tan, C. Tan, and H. Shen, Alpha synuclein promoter and risk of Parkinson's disease: microsatellite and allelic size variability Australian data and meta-analysis lend support for alphasynuclein (NACP-Rep1) as a risk factor for Parkinson's disease Association of -synuclein REP1 polymorphism and Parkinson's disease: influence of REP1 on age at onset al. Mutation , sequence analysis, and association studies of -synuclein in Parkinson's disease, Neurosci Lett. Neurosci Lett. Mov Disord. Neurology, vol.33637521, issue.51, pp.70-72112, 1998.

N. Khan, E. Graham, and P. Dixon, Parkinson's disease is not associated with the combined -synuclein/ apolipoprotein E susceptibility genotype NACP- REP1 polymorphism is not involved in Parkinson's disease: a case-control study in a population sample from southern Italy, Ann Neurol. Neurosci Lett, vol.49351, issue.28, pp.665-66875, 2001.

Y. Izumi, H. Morino, and M. Oda, Genetic studies in Parkinson's disease with an -synuclein/NACP gene polymorphism in Japan Meta-analysis of -synuclein/NACP polymorphism in Parkinson's disease in Japan [letter] Replication validity of genetic association studies Rocca WA. Analysis, reanalysis, and metaanalysis in neurology Investigating Neurological Diseases: Epidemiology for Clinical Neurology Commentary: meta-analysis of individual participants' data in genetic epidemiology, Neurosci Lett. J Neurol Neurosurg Psychiatry. Nat Genet. Am J Epidemiol, vol.30029156, issue.2001, pp.125-12773, 2001.

M. Sapru, J. Yates, S. Hogan, L. Jiang, J. Halter et al., Silencing of human ??-synuclein in vitro and in rat brain using lentiviral-mediated RNAi, Experimental Neurology, vol.198, issue.2, pp.382-390, 2006.
DOI : 10.1016/j.expneurol.2005.12.024

D. Maraganore, T. Lesnick, and A. Elbaz, UCHL1 is a Parkinson's disease susceptibility gene Quantifying heterogeneity in a meta-analysis Measuring inconsistency in meta-analyses Meta-analysis in clinical trials Bias in meta-analysis detected by a simple, graphical test Score tests for association between traits and haplotypes when linkage phase is ambiguous, Ann Neurol. Stat Med. BMJ. Control Clin Trials. BMJ. Am J Hum Genet, vol.5521731570, issue.38, pp.512-5211539, 1986.

D. Gelb, E. Oliver, and S. Gilman, Diagnostic Criteria for Parkinson Disease, Archives of Neurology, vol.56, issue.1, pp.33-39, 1999.
DOI : 10.1001/archneur.56.1.33

D. Gibb, A. Lees, J. Langston, H. Widner, and C. Goetz, The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease Core assessment program for intracerebral transplantations (CAPIT), J Neurol Neurosurg Psychiatry. Mov Disord, vol.517, issue.43, pp.745-7522, 1988.

J. Bower, D. Maraganore, S. Mcdonnell, W. Rocca, V. Everbroeck et al., Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990 Casecontrol study of environmental risk factors for Parkinson's disease in Belgium, Neurology. Eur J Epidemiol, vol.5218, pp.1214-1220, 1999.

J. Ioannidis, . Genetic, S. Wacholder, S. Chanock, M. Garcia-closas et al., Assessing the probability that a positive report is false: an approach for molecular epidemiology studies Hardy-Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations , and power, Ioannidis JP. Why most published research findings are false, pp.135-138, 2003.

T. Trikalinos, G. Salanti, M. Khoury, and J. Ioannidis, Impact of Violations and Deviations in Hardy-Weinberg Equilibrium on Postulated Gene-Disease Associations, American Journal of Epidemiology, vol.163, issue.4, pp.300-309, 2006.
DOI : 10.1093/aje/kwj046

E. Tan, A. Chai, and Y. Teo, Alpha-synuclein haplotypes implicated in risk of Parkinson's disease, Neurology, vol.62, issue.1, pp.128-131, 2004.
DOI : 10.1212/01.WNL.0000101721.25345.DC

J. Mueller, J. Fuchs, and A. Hofer, Multiple regions of ??-synuclein are associated with Parkinson's disease, Annals of Neurology, vol.100, issue.4, pp.535-541, 2005.
DOI : 10.1002/ana.20438

B. Neale and P. Sham, The Future of Association Studies: Gene-Based Analysis and Replication, The American Journal of Human Genetics, vol.75, issue.3, pp.353-362, 2004.
DOI : 10.1086/423901

D. Maraganore, M. De-andrade, and T. Lesnick, High-Resolution Whole-Genome Association Study of Parkinson Disease, The American Journal of Human Genetics, vol.77, issue.5, pp.685-6933, 2005.
DOI : 10.1086/496902

D. Maraganore, M. De-andrade, and T. Lesnick, Complex interactions in Parkinson's disease: A two-phased approach, Movement Disorders, vol.299, issue.Suppl. 1, pp.631-636, 2003.
DOI : 10.1002/mds.10431

C. Mamah, T. Lesnick, and S. Lincoln, Interaction of ?-synuclein and tau genotypes in Parkinson's disease, Annals of Neurology, vol.56, issue.3, pp.439-443, 2005.
DOI : 10.1002/ana.20387